Samuel Gandy

Search results

• Icahn School of Medicine at Mount Sinai Researchers Release New Data on Amyloid [Dual-specificity protein phosphatase 6 (DUSP6) overexpression reduces amyloid load and improves memory deficits in male 5xFAD mice]

  Beckmann, N., Wang, Q., Schadt, E., Wang, M., Ehrlich, M. & Gandy, S.

  15/07/24

  1 item of Media coverage

  Press/Media

• Might SORL1 Bind Tau in Glia, Fuel Its Aggregation?

  Gandy, S.

  4/05/24

  1 item of Media coverage

  Press/Media

• Portland man takes part in drug trial giving new hope in fight against Alzheimer’s disease

  Gandy, S.

  22/01/24

  3 items of Media coverage

  Press/Media

• Portland man takes part in drug trial giving new hope in fight against Alzheimer’s disease

  Gandy, S.

  22/01/24

  1 item of Media coverage

  Press/Media

• Portland man takes part in drug trial giving new hope in fight against Alzheimer's disease Ralph Carmona participated in a clinical research trial for Leqembi, a new Alzheimer's drug that he believes stopped his symptoms from progressing.

  Gandy, S.

  22/01/24

  1 item of Media coverage

  Press/Media

• Portland man takes part in Alzheimer’s drug trial

  Gandy, S.

  22/01/24

  1 item of Media coverage

  Press/Media

• Brain Networks May Benefit from Walking: More study results add to growing evidence that exercise mitigates cognitive impairment.(NEUROLOGY)

  Gandy, S.

  1/01/24

  1 item of Media coverage

  Press/Media

• Investigators at University San Pablo-CEU Report Findings in Frontotemporal Dementia (New Developments of Biofluid-based Biomarkers for Routine Diagnosis and Disease Trajectories In Frontotemporal Dementia)

  Gandy, S.

  11/12/23

  1 item of Media coverage

  Press/Media

• AltPep Further Strengthens Advisory Board with Appointment of Steven E. Kahn, M.B., Ch.B.

  Gandy, S.

  14/11/23 → 15/11/23

  9 items of Media coverage

  Press/Media

• AltPep Further Strengthens Advisory Board with Appointment of Steven E. Kahn, M.B., Ch.B.

  Gandy, S.

  15/11/23

  1 item of Media coverage

  Press/Media

• Can new drug donanemab really slow the growth of Alzheimer's disease?

  Gandy, S.

  18/07/23

  1 item of Media coverage

  Press/Media

• FDA gives Alzheimer's drug full approval; Medicare says it will broadly cover the medicine, which costs $26,500 annually

  Gandy, S.

  7/07/23

  1 item of Media coverage

  Press/Media

• FDA grants full approval for Biogen Alzheimer's drug that slows cognitive decline; The medicine, developed by Eisai and Cambridge-based Biogen, is expected to be covered by Medicare

  Gandy, S.

  6/07/23

  1 item of Media coverage

  Press/Media

• Science Reveals Key Driver of Alzheimer's, and How Newly Approved Drug, Leqembi, May Fight It

  Gandy, S.

  15/05/23

  1 item of Media coverage

  Press/Media

• Science Reveals Key Driver of Alzheimer's, and How Newly Approved Drug May Fight It.(lecanemab)

  Gandy, S.

  10/05/23

  1 item of Media coverage

  Press/Media

• Science Reveals Key Driver of Alzheimer's, and How Newly Approved Drug May Fight It

  Gandy, S.

  10/05/23

  92 items of Media coverage

  Press/Media

• Key Alzheimer's Driver Revealed, New Drug Effective

  Gandy, S.

  10/05/23

  2 items of Media coverage

  Press/Media

• Science Reveals Key Driver of Alzheimer's, and How Newly Approved Drug May Fight It

  Gandy, S.

  10/05/23

  1 item of Media coverage

  Press/Media

• Could High Laxative Usage Raise the Odds for Dementia?

  Gandy, S.

  1/03/23

  1 item of Media coverage

  Press/Media

• Studies Conducted at Renaissance School of Medicine at Stony Brook University on Traumatic Stress Disorders Recently Published (Genetic Liability, Exposure Severity, and Post-Traumatic Stress Disorder Predict Cognitive Impairment in World Trade ...)

  Gandy, S.

  23/02/23

  1 item of Media coverage

  Press/Media

• Reports from New York University (NYU) Add New Data to Findings in Gene Therapy (The Contribution of Amyloid Deposition In the Aortic Valve To Calcification and Aortic Stenosis)

  Gandy, S.

  21/02/23

  1 item of Media coverage

  Press/Media

• AltPep Strengthens Advisory Board with Three Leading Experts in Alzheimer's Disease and Neurodegenerative Disorders; Newly appointed advisors will further support AltPep's research and clinical development of early detection and treatment alternatives for

  Gandy, S.

  9/02/23

  2 items of Media coverage

  Press/Media

• AltPep Strengthens Advisory Board with Three Leading Experts in Alzheimer’s Disease and Neurodegenerative Disorders

  Gandy, S.

  9/02/23

  2 items of Media coverage

  Press/Media

• AltPep Strengthens Advisory Board with Three Leading Experts in Alzheimer’s Disease and Neurodegenerative Disorders

  Gandy, S.

  9/02/23

  7 items of Media coverage

  Press/Media

• New Findings Reported from Icahn School of Medicine at Mount Sinai Describe Advances in Alzheimer Disease [Dual-specificity Protein Phosphatase 4 (Dusp4) Overexpression Improves Learning Behavior Selectively In Female 5xfad Mice, and Reduces ...]

  Wang, Q., Wang, M., Gandy, S., Beckmann, N., Schadt, E. & Ehrlich, M.

  16/01/23

  1 item of Media coverage

  Press/Media